Prelude Therapeutics(PRLD)
$3.45-0.07 (-1.99%)
PRLD
Prelude Therapeutics earnings date
$3.45
At close:-0.07 (-1.99%)
Want to see PRLD full AI Analyst Report?
Prelude Therapeutics (PRLD) Q4 2022 Earnings Report
196 Followers
PRLD Q4 2022 EPS Results
- Actual EPS
- -$0.60
- Consensus EPS
- -$0.63
- Beat/Miss
- Beat by +$0.03
- One Year Ago EPS
- -$0.71
PRLD Q4 2022 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 03/15/2023
- Time
- Before Open
- Conference Call
- Wednesday, March 15, 2023
PRLD Upcoming Earnings
Prelude Therapeutics's next earnings date is estimated for March 16, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
PRLD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 16, 2027 | 2026 (Q4) | ―- | -0.2 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.01- | -0.26 | ― | |
| Aug 19, 2026 | 2026 (Q2) | -0.20-0.14 | -0.41 | 65.85% (+0.27) | |
| May 12, 2026 | 2026 (Q1) | -0.25-0.13 | -0.42 | 69.05% (+0.29) | |
| Mar 10, 2026 | 2025 (Q4) | -0.03-0.20 | -0.37 | 45.95% (+0.17) | |
| Nov 12, 2025 | 2025 (Q3) | -0.37-0.26 | -0.43 | 39.53% (+0.17) | |
| Aug 14, 2025 | 2025 (Q2) | -0.44-0.41 | -0.46 | 10.87% (+0.05) | |
| May 06, 2025 | 2025 (Q1) | -0.47-0.42 | -0.42 | 0.00% (+0.00) | |
| Mar 10, 2025 | 2024 (Q4) | -0.46-0.37 | -0.45 | 17.78% (+0.08) | |
| Nov 06, 2024 | 2024 (Q3) | -0.47-0.43 | -0.45 | 4.44% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

